FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Innere Medizin (Nephrologie)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 4 – Nephrology and Hypertension
Lehrstuhl für Innere Medizin IV
Overview
Publications
(404)
Research Grants
(1)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023)
Barbato E, Azizi M, Schmieder R, Lauder L, Böhm M, Brouwers S, Bruno RM, et al.
Journal article
LONG-TERM REDUCTION IN MORNING AND NIGHTTIME BLOOD PRESSURE AFTER RENAL DENERVATION: 36-MONTH RESULTS FROM SPYRAL HTN-ON MED PILOT TRIAL (2023)
Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al.
Conference contribution
BLOOD PRESSURE REDUCTION AFTER RENAL DENERVATION IN PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: THE ERLANGER EXPERIENCE (2023)
Schmid A, Ott C, Bosch A, Schiffer M, Uder M, Schmieder R, Kannenkeril D
Conference contribution
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure (2023)
Bosch A, Poglitsch M, Kannenkeril D, Kolwelter J, Striepe K, Ott C, Rauh M, et al.
Journal article
Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results From the SPYRAL HTN-ON Med Expansion Randomized Trial (2022)
Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder R, Pocock S, et al.
Conference contribution
Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes (2022)
Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al.
Journal article
New strategies to improve clinical outcomes for diabetic kidney disease (2022)
Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder R, Halabi A, et al.
Journal article, Review article
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk (2022)
Boehm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, et al.
Journal article
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range (2022)
Mahfoud F, Mancia G, Schmieder R, Ruilope L, Narkiewicz K, Schlaich M, Williams B, et al.
Journal article
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial (2022)
Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder R, Lurz P, Lobo MD, et al.
Journal article
‹
1
...
4
5
6
7
8
...
41
›